deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT05721235

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD (KP415P02)

A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder

Sponsor: Almac

Updated 8 times since 2023 Last updated: Sep 9, 2025 Started: Jun 2, 2023 Primary completion: Aug 29, 2025 Completion: Aug 29, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Attention Deficit/Hyperactivity Disorder, this trial is completed. The trial is conducted by Almac and has accumulated 8 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshot~Jun 2023 – ~Feb 2024 · 8 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotActive Not Recruiting~Jul 2025 – ~Oct 2025 · 3 months · monthly snapshot~Oct 2025 – ~Dec 2025 · 2 months · monthly snapshot~Dec 2025 – present · 7 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Dec 2025 — Present [monthly]

    Completed PHASE4

  2. Oct 2025 — Dec 2025 [monthly]

    Completed PHASE4

    Status: Active Not RecruitingCompleted

  3. Jul 2025 — Oct 2025 [monthly]

    Active Not Recruiting PHASE4

  4. Sep 2024 — Jul 2025 [monthly]

    Active Not Recruiting PHASE4

    Status: RecruitingActive Not Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

Show 3 earlier versions
  1. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE4

  2. Jun 2023 — Feb 2024 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  3. Mar 2023 — Jun 2023 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Almac
  • Corium, Inc.
  • Premier Research
  • Prometrika, LLC
  • Worldwide Clinical Trials
Data source: Corium, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .